Sunrun Inc. (NASDAQ:RUN – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Wednesday after Susquehanna lowered their price target on the stock from $15.00 to $13.00. Susquehanna currently has a positive rating on the stock. Sunrun traded as low as $7.23 and last traded at $7.3650, with a volume of 2,169,315 shares trading hands. The stock had previously closed at $7.79.
RUN has been the topic of several other research reports. Wells Fargo & Company cut their price objective on shares of Sunrun from $22.00 to $17.00 and set an “overweight” rating on the stock in a report on Friday, August 14th. The Goldman Sachs Group lowered their target price on shares of Sunrun from $13.00 to $11.00 and set a “buy” rating for the company in a research note on Thursday, October 8th. Barclays dropped their target price on shares of Sunrun from $14.00 to $12.00 and set an “equal weight” rating on the stock in a research report on Friday. Wall Street Zen lowered shares of Sunrun from a “hold” rating to a “sell” rating in a research note on Saturday. Finally, Mizuho set a $18.00 price target on shares of Sunrun in a report on Thursday, August 6th. Twelve research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $15.81.
View Our Latest Stock Analysis on Sunrun
Insider Activity
Institutional Investors Weigh In On Sunrun
A number of hedge funds have recently modified their holdings of RUN. Contour Asset Management LLC acquired a new position in Sunrun in the fourth quarter valued at approximately $98,010,000. Bank of America Corp DE acquired a new stake in Sunrun in the second quarter valued at approximately $29,953,000. Bank of New York Mellon Corp purchased a new stake in Sunrun during the 2nd quarter worth about $18,120,000. Amundi lifted its position in shares of Sunrun by 56.3% during the 1st quarter. Amundi now owns 3,300,626 shares of the energy company’s stock worth $44,798,000 after buying an additional 1,188,564 shares during the last quarter. Finally, Deutsche Bank AG purchased a new stake in shares of Sunrun in the 2nd quarter valued at about $12,483,000. 91.69% of the stock is currently owned by institutional investors and hedge funds.
Sunrun Stock Performance
The stock’s 50 day moving average is $8.73 and its two-hundred day moving average is $11.45. The company has a current ratio of 1.42, a quick ratio of 1.00 and a debt-to-equity ratio of 3.34. The stock has a market cap of $1.77 billion, a price-to-earnings ratio of 4.99 and a beta of 2.44.
Sunrun (NASDAQ:RUN – Get Free Report) last released its earnings results on Wednesday, August 5th. The energy company reported $0.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.23 by $0.19. Sunrun had a return on equity of 9.59% and a net margin of 11.59%. The business had revenue of $869.99 million for the quarter, compared to analyst estimates of $746.87 million. During the same quarter in the previous year, the company posted $1.07 earnings per share. The company’s revenue for the quarter was up 52.8% compared to the same quarter last year. Analysts anticipate that Sunrun Inc. will post 1.16 earnings per share for the current fiscal year.
About Sunrun
Sunrun Inc is a residential solar energy company that designs, installs, owns and maintains solar energy systems for homeowners. The company typically provides electricity through long-term agreements, including solar leases and power purchase agreements, allowing customers to use electricity generated by rooftop solar systems without purchasing the equipment outright.
Sunrun also offers energy storage solutions, including its BrightBox battery system, which can store electricity for use during outages, periods of high demand or when solar generation is unavailable.
Further Reading
- Five stocks we like better than Sunrun
- High Voltage Returns: Navitas Rewires AI Data Centers
- Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built
- Albertsons Is Betting on a Turnaround—But Will It Pay Off?
- Venezuela’s Oil Revival Is Gaining Momentum—3 Energy Stocks Positioned to Benefit
Receive News & Ratings for Sunrun Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sunrun and related companies with MarketBeat.com's FREE daily email newsletter.
